Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102056966A details a novel mixed catalyst process for polyaminopolyphenyl methanes, offering reduced impurities and extended catalyst life for cost-effective manufacturing.
Novel hydrocyanation process using nickel catalyst enhances purity and yield for nitrile compounds, offering cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN103467356A reveals a metal-free aqueous route for tetrahydroindoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113816836A details enzymatic route for liver drug intermediate. High purity, scalable, cost-effective supply chain solution.
Patent CN112609202B enables green electrocatalytic synthesis of Xanthoisoxazoline B. Offers cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN120718880A reveals high-efficiency biocatalysis for chiral amines. Achieve superior purity and reduced manufacturing costs with scalable enzyme technology.
Discover green synthesis of 2,4-dichloroacetophenone via ionic liquid catalysis. Enhances purity and reduces waste for reliable pharmaceutical intermediates supply chains.
Discover high-purity USP7 inhibitor intermediates based on patent CN115215883A. Optimized synthesis routes offer significant cost reduction and supply chain reliability for oncology drug development.
Patent CN111423331B reveals a green TiO2-Ni photocatalytic route for aryl alkyl ethers. Discover cost-effective, scalable manufacturing for Prozac intermediates.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105152831A reveals high-yield asymmetric synthesis. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of binaphthyl NN-dioxide ligands via Pd-catalyzed carbonylation. High yield over 75 percent and purity exceeding 95 percent. Reliable supplier for asymmetric catalysis.
Patent CN113896703A reveals a high-yield green synthesis of daidzein using BF3 and P2O5, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116875575A reveals mutant enzyme for L-glufosinate. Achieves 99% conversion in 4h. Offers cost reduction and supply chain reliability for agrochemical manufacturing.
Novel solid-base catalyzed route for oxiracetam intermediate ensures high purity and scalable manufacturing for global pharmaceutical supply chains and cost efficiency.
Patent CN111925343A details a high-yield synthesis for Linezolid degradation impurities. Discover cost-effective manufacturing and supply chain advantages for API quality control.
Patent CN111606876A details a novel metal-free synthesis of 2-(2-oxo-2-phenethoxy)isobenzyl-1,3-dione using oxygen, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN120554424A reveals a novel ferrocene-based P,N,N-ligand offering superior stability and stereoselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN110156873B reveals a novel NdSe2-catalyzed route for Fmoc-D-Pro-D-Pro-OH, offering >98.5% purity and streamlined manufacturing for peptide intermediates.
Patent CN104178540A details a novel E. coli method for ademetionine. Offers high purity and yield for pharmaceutical intermediates manufacturing supply chains.